This page provides information and guidance on gynaecological cancer for health care professionals.
Information for patients can be found on our patient hub.
If would like further information on the Gynaecological CSG please click here to contact us.
The National Optimal Pathways for Gynaecological Cancer were developed in conjunction with the Gynaecological CSG to support the implementation of the Single Cancer Pathway (SCP) in Wales.
To view the Gynaecological National Optimal Pathways click here.
All Wales Guidelines - Cervical Cancer, 2019
All Wales Guidelines - Ovarian, Fallopian tube and Primary Peritoneal Cancer, 2021
All Wales Guidelines - Uterine Cancer, 2019
All Wales Guidelines - Vulval Cancer, 2023
All Wales Guidelines - Testing for lynch syndrome in people with endometrial cancer, 2021
All Wales Guidelines - Gynaecological Cancer Follow-up, 2021
South Wales Gynaecological Cancer Guidelines 2011 - These guidelines are in the process of being reviewed at an All Wales level
Contact details can be accessed via the NHS Wales Global address list. If you do not have access to this please click here to contact us.
|
Health Board / MDT |
MDT Lead | MDT Frequency |
| Aneurin Bevan UHB | Mrs Leena Gokhale |
Wednesdays 8:15am Weekly |
| Betsi Cadwaladr UHB | Mr Richard Peevor |
Mondays 2pm Weekly |
| Cardiff & Vale UHB | Mr Ken Lim |
Wednesdays 8am Weekly |
|
Cwm Taf Morgannwg UHB (Prince Charles & Royal Glamorgan Hospitals) |
Mr Mohamed Khalifa |
Wednesdays 12:30pm Weekly |
| Hywel Dda UHB | Mr Islam Abdelrahman |
Wednesdays 9am Weekly |
| Swansea Bay UHB | Mr Kerryn Lutchman-Singh |
Wednesdays 8am Weekly |
The Cancer Network education event 'Endometrial Cancer: POLE testing, molecular classification and lynch syndrome' took place on the 22nd July 2022. CLICK HERE to view the event recording.
The Cancer Network HRD Pathway Workshop took place virtually on 17th June 2022. CLICK HERE to view the workshop recording.
For further information click here to contact us.